H 2 S Self‐Supplied Micelles Reverse Tumor‐Immune Effector Cells Energy Metabolisms to Boost Breast Cancer Immunotherapy With Microenvironment Normalization
Advanced Materials · 2026-08 · 38 (46)
DOI: 10.1002/adma.74041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 07.07.2026. Verfasst von Siyu Meng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Northwestern Polytechnical University, Xi'an, China. Hauptthemen laut MEDLINE: Micelles, Tumor Microenvironment, Hydrogen Sulfide, Immunotherapy. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shaanxi Provincial Outstanding Natural Science Foundation, Key Research and Development Program of Shaanxi Province.
Abstract (Originalsprache)
Reversing the immunosuppressive tumor microenvironment by targeting metabolic competition between tumors and immune effector cells could induce tumor starvation and enhance the activity of immune cells, representing a potential approach to boost tumor immunotherapy. However, its actual efficacy is limited by compensatory oxidative phosphorylation (OXPHOS) energy replenishment and low delivery efficiency. Herein, we report a hydrogen sulfide (H 2 S)‐self‐supplying nanoplatform that orchestrates a dual blockade of glycolysis and OXPHOS for improved triple‐negative breast cancer (TNBC) immunotherapy. The micellar system, HA‐ADT@W, achieves tumor‐targeted delivery of a glycolysis inhibitor (WZB117) and H 2 S continually released in GSH‐overexpressed tumor cells. This strategy concurrently suppresses glucose uptake in tumor cells by reversing the acidic tumor microenvironment (TME) and disrupts compensatory OXPHOS via H 2 S‐mediated inhibition of cytochrome c oxidase. Consequently, we demonstrate a significant rewiring of tumor energy metabolism that not only induces immunogenic cell death with remodeling of the immunosuppressive TME but also alleviates nutrient constraints of immune effector cells, leading to enhanced infiltration and function of cytotoxic immune cells. This work exhibits a smart nanoplatform‐based H 2 S self‐supplied micelle for reinforced TNBC immunotherapy via regulated metabolic competition between tumors and immune effector cells with TME normalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Northwestern Polytechnical University, Xi'an, China.
- School of Medicine, University of Nottingham, Nottingham, UK.
ORCID-Profile: Liangliang Dai
Förderung
- National Natural Science Foundation of China
- Shaanxi Provincial Outstanding Natural Science Foundation
- Key Research and Development Program of Shaanxi Province
Zitieren
APA
Meng, S., Wei, X., Wang, Z., Chen, S., Chen, K., Cheng, J., Chen, Z., Liang, J., & Dai, L. (2026). H 2 S Self‐Supplied Micelles Reverse Tumor‐Immune Effector Cells Energy Metabolisms to Boost Breast Cancer Immunotherapy With Microenvironment Normalization. Advanced Materials, 38(46). https://doi.org/10.1002/adma.74041
Vancouver
Meng S, Wei X, Wang Z, Chen S, Chen K, Cheng J, et al. H 2 S Self‐Supplied Micelles Reverse Tumor‐Immune Effector Cells Energy Metabolisms to Boost Breast Cancer Immunotherapy With Microenvironment Normalization. Advanced Materials. 2026;38(46). doi:10.1002/adma.74041
BibTeX
@article{Meng2026,
author = {Meng, Siyu and Wei, Xuan and Wang, Ziyan and Chen, Siyu and Chen, Keying and Cheng, Jiamin and Chen, Zheng and Liang, Jiabao and Dai, Liangliang},
title = {H 2 S Self‐Supplied Micelles Reverse Tumor‐Immune Effector Cells Energy Metabolisms to Boost Breast Cancer Immunotherapy With Microenvironment Normalization},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {46},
doi = {10.1002/adma.74041}
}
EUVIMED